Publications

Lee YJ, Jeon SH, Yeo JH, Byeon SJ, Jung JH, Nam H, Jeon M, Kim ES, Jang JY, Kim CH, Chung KY, Lee JY, Hwang S, Kim JY, Kim SI, Cheong JH, Kim CG, Shin SJ, Park SH, Jung M, Kang M (Co-correspondence), Seo SI, Shin EC. Tumor-specific but immunosuppressive CD39+CD8+ T cells exhibit double-faceted roles in clear cell renal cell carcinoma. Cell Rep Med. 2025 Sep 16:102360. doi: 10.1016/j.xcrm.2025.102360. PMID: 40961944 

Lee J, Kim Y, Lee C, Jeon SS, Seo H, Lee J, Choi J, Kang M (Co-correspondence) Kim E, Shin K. Generation of prostate cancer assembloids modeling the patient-specific tumor microenvironment. PLoS Genet. 2025 Mar 31;21(3):e1011652. doi: 10.1371/journal.pgen.1011652. eCollection 2025 Mar. PMID: 40163511 

Yu J, Ahn H, Han KY, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Park SH, Park WY, Lee JH, Kang M (Correspondence). Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma. J Cachexia Sarcopenia Muscle. 2025 Apr;16(2):e13758. doi: 10.1002/jcsm.13758. PMID: 40052383 

Lee CR, Suh J, Jang D, Jin BY, Cho J, Lee M, Sim H, Kang M, Lee J, Park JH, Lee KH, Hwang GS, Moon KC, Song C, Ku JH, Kwak C, Kim HH, Cho SY, Choi M, Jeong CW. Comprehensive molecular characterization of TFE3-rearranged renal cell carcinoma. Exp Mol Med. 2024 Aug;56(8):1807-1815. doi: 10.1038/s12276-024-01291-2. Epub 2024 Aug 1. PMID: 39085357

Lee S, Kim JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Park SH, Lee JH, Yu J, Kang M (Correspondence). Prognostic Role of Pre-Treatment Body Composition Parameters in Patients Undergoing First-Line Immunotherapy for Metastatic Renal Cell Carcinoma. Cancer Manag Res. 2024 Aug 28;16:1091-1101. doi: 10.2147/CMAR.S476150. eCollection 2024. PMID: 39220816 

Lee J, Lee K, Bae H, Lee K, Lee S, Ma J, Jo K, Kim I, Jee B, Kang M, Im SJ. IL-15 promotes self-renewal of progenitor exhausted CD8 T cells during persistent antigenic stimulation. Front Immunol. 2023 Jun 20;14:1117092. doi: 10.3389/fimmu.2023.1117092. eCollection 2023. PMID: 37409128 

Jeong SR, Kang M (Correspondence). FExploring Tumor-Immune Interactions in Co-Culture Models of T Cells and Tumor Organoids Derived from Patients. Int J Mol Sci. 2023 Sep 27;24(19):14609. doi: 10.3390/ijms241914609. PMID: 37834057

Lee JH, Hwang S, Jee B, Kim JH, Lee J, Chung JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park SH, Kwon GY,  Kang M (Correspondence). Fat Loss in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors. Int J Mol Sci. 2023 Feb 16;24(4):3994. doi: 10.3390/ijms24043994. PMID: 36835404 

Jeon SH, Kang M (co-1st author), Jeon M, Chung Y, Kim AR, Lee YJ, Kim ES, Nam H, Park J, Lee JY, Shin EC, Seo SI, Park SH. CEACAM1 marks highly suppressive intratumoral regulatory T cells for targeted depletion therapy. Clin Cancer Res. 2023 Jan 30:CCR-22-1843. Online ahead of print. PMID: 36716293

Lee CU, Cho E, Lee J, Lim JE, Chung JH, Song W, Kang M, Sung HH, Jeong BC, Seo SI, Jeon SS, Lee HM, Jeon HG. Chromosomal Instability in Cell-free DNA as a Prognostic Biomarker of Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Focus. 2023 Jan;9(1):89-95. doi: 10.1016/j.euf.2022.09.002. PMID: 36167777

Seo E and Kang M (Correspondence). Current status and clinical application of patient-derived tumor organoid model in kidney and prostate cancers. BMB Rep. 2022 Dec 7;5814. Online ahead of print. PMID: 36476272

Seo E, Jee BA, Chung JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Kang M (Correspondence). Repression of SLC22A3 by the AR-V7/YAP1/TAZ axis in enzalutamide-resistant castration-resistant prostate cancer. FEBS J. 2022 Oct 18. doi: 10.1111/febs.16657. PMID: 36254631 

Jee B, Seo E, Park K, Kim YR, Byeon SJ, Lee SM, Chung JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park SH, Park WY, Kang M (Correspondence). Molecular Subtypes Based on Genomic and Transcriptomic Features Correlate with the Responsiveness to Immune Checkpoint Inhibitors in Metastatic Clear Cell Renal Cell Carcinoma. Cancers (Basel). 2022 May 10;14(10):2354.  PMID: 35625960

Song JW, Suh J, Lee SW, Yoo JK, Lee U, Han JH, Kwak C, Kang M, Kim YR, Jeong CW, Choi JW. Isolation and Genomic Analysis of Single Circulating Tumor Cell Using Human Telomerase Reverse Transcriptase and Desmoglein-2.  Small Methods. 2022 Apr;6(4):e2100938.  PMID: 35038250 

Kang M (1st author), Lee H, Byeon SJ, Kwon GY, Jeon SS. Genomic Features and Clinical Implications of Intraductal Carcinoma of the Prostate. Int J Mol Sci. 2021 Dec 4;22(23):13125.  PMID: 34884926

Lee JH, Jee BA, Kim JH, Bae H, Chung JH, Song W, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park SH, Kang M (Correspondence). Prognostic Impact of Sarcopenia in Patients with Metastatic Hormone-Sensitive Prostate Cancer. Cancers (Basel). 2021 Dec 17;13(24):6345.  PMID: 34944964 

Choi JB, Lee J, Kang M, Kim B, Ju Y, Do HS, Yoo HW, Lee BH, Han YM. Dysregulated ECM remodeling proteins lead to aberrant osteogenesis of Costello syndrome iPSCs. Stem Cell Reports. 2021 Jun 25:S2213-6711(21)00313-1.  PMID: 34242618 

Yoo GS, Park W, Pyo H, Jeong BC, Jeon HG, Kang M, Seo SI, Jeon SS, Lee HM, Choi HY, Park BK, Kim CK, Park SY, Kwon GY.  Risk Factors and Patterns of Locoregional Recurrence After Radical Nephrectomy for Locally Advanced Renal Cell Carcinoma. Cancer Res Treat. 2021 Apr 15. doi: 10.4143/crt.2020.1373. PMID: 33857365

Kim YJ, Kang Y, Kim JS, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM, Park D, Park WY, Kang M (Correspondence). Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma. Sci Rep. 2021 Mar 10;11(1):5600. doi: 10.1038/s41598-021-85099-4. PMID: 33692449

Yu J, Cho E, Choi J, Lim JE, Lee J, Kang M, Sung HH, Jeong BC, Seo SI, Jeon SS, Lee HM, Jeon HG. Genomic mutation profiling using liquid biopsy in Korean patients with prostate cancer: Circulating tumor DNA mutation predicts the development of castration resistance. Investig Clin Urol. 2021 Mar;62(2):224-232. doi: 10.4111/icu.20200406. PMID: 33660451

Lee CH, Chung J, Kwak C, Jeong CW, Seo SI, Kang M, Hong SH, Song C, Park JY, Hwang EC, Lee H, Ku JY, Seo WI, Choi SH, Ha HK; Korean Renal Cancer Study Group. Targeted therapy response in early versus late recurrence of renal cell carcinoma after surgical treatment: A propensity score-matched study using the Korean Renal Cancer Study Group database. Int J Urol. 2021 Feb 1. doi: 10.1111/iju.14485. PMID: 33527588

Shin TJ, Song C, Jeong CW, Kwak C, Seo S, Kang M, Chung J, Hong SH, Hwang EC, Park JY, Lee H Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome. J Surg Oncol. 2021 Jan;123(1):204-213. doi: 10.1002/jso.26251. PMID: 33047324

Kim E, Choi S, Kang B, Kong J, Kim Y, Yoon WH, Lee HR, Kim S, Kim HM, Lee H, Yang C, Lee YJ, Kang M, Roh TY, Jung S, Kim S, Ku JH, Shin K. Creation of bladder assembloids mimicking tissue regeneration and cancer. Nature. 2020 Dec 16. doi: 10.1038/s41586-020-3034-x. Online ahead of print. PMID: 33328632

Chung JH, Yu J, Song W, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Lee HM, Jeon SS. Strategy for Prostate Cancer Patients with Low Prostate Specific Antigen Level (2.5 to 4.0 ng/mL). J Korean Med Sci. 2020 Oct 26;35(41):e342. doi: 10.3346/jkms.2020.35.e342. PMID: 33107227 

Choi J, Kang M, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Lee HM. Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5-10 ng/mL. Investig Clin Urol. 2020 Nov;61(6):582-587. doi: 10.4111/icu.20200084. PMID: 33135403

Kang M (1st author), Choi J, Kim J, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Park S . Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis. J Cancer. 2020 Oct 18;7202-7208. PMID: 33193883

Shin TJ, Song C, Jeong CW, Kwak C, Seo S, Kang M, Chung J, Hong SH, Hwang EC, Park JY, Lee H . Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome. J Surg Oncol. 2020 Oct 12. PMID: 33047324

Lee EJ, Ko JY, Oh S, Jun J, Mun H, Lim CJ, Seo S, Ko HW, Kim H, Oh YK, Ahn C, Kang M, Kim MJ, Yoo KH, Oh GT, Park JH.  Autophagy induction promotes renal cyst growth in polycystic kidney disease. EBioMedicine. 2020 Sep 16;60:102986. PMID: 32949996 

Rho MJ, Park J, Moon HW, Lee C, Nam S, Kim D, Kim CS, Jeon SS, Kang M, Lee JY.  Dr. Answer AI for prostate cancer: Clinical outcome prediction model and service. PLoS One. 2020 Aug 5;15(8):e0236553. PMID: 32756597  

Kang M (1st author), Shin SJ, HH Sung SH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Seo SI. Clinical Significance of Pre-to-Postoperative Dynamics of Aspartate Transaminase/Alanine Transaminase Ratio in Predicting the Prognosis of Renal Cell Carcinoma after Surgical Treatment. Dis Markers. 2020 Jul; 2020: 8887605. PMID: 32724485

Kim JH, Han JW, Choi YJ, Rha MS, Koh JY, Kim KH, Kim CG, Lee YJ, Kim AR, Park J, Kim HK, Min BS, Seo SI, Kang M, Park HJ, Han DH, Kim SI, Kim MS, Lee JG, Lee DH, Kim W, Park JY, Park SH, Joo DJ, Shin EC. Functions of Human Liver CD69 + CD103 - CD8 + T Cells Depend on HIF-2α Activity in Healthy and Pathologic Livers. J Hepatol. 2020 Jun;72(6):1170-1181. PMID: 31987989

Yuk HD, Hwang EC, Park JY, Jeong CW, Song C, Seo SI, Byun SS, Kwak C, Hong SH, Kang M, Chung J, Lee H. The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma. Sci Rep. 2020 Apr 24;10(1):6967. doi: 10.1038/s41598-020-63816-9. PMID: 32332797

Choi CI, Kang M, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Seo SI. Comparison by Pentafecta Criteria of Transperitoneal and Retroperitoneal Robotic Partial Nephrectomy for Large Renal Tumors. J Endourol. 2020 Feb;34(2):175-183. PMID: 31621405

Jung SI, Kim MS, Jeong CW, Kwak C, Hong SK, Kang SH, Joung JY, Lee SH, Yun SJ, Kim TH, Park SW, Jeon SS, Kang M, Lee JY, Chung BH, Hong JH, Ahn H, Kim CS, Kwon DD. Enzalutamide in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer: A Retrospective Korean Multicenter Study in a Real-World Setting. Investig Clin Urol. 2020 Jan;61(1):19-27. PMID: 31942459

Shin SJ, Kim T, Sung HH, Jeon HG, Jeong BC, Park SH, Jeon SS, Lee HM, Choi HY, Seo SI, Kang M. Novel Predictive Models of Early Death Less Than 1 Year in Patients With Metastatic Renal Cell Carcinoma After Treatment With First-line Tyrosine Kinase Inhibitors. Clin Genitourin Cancer. 2019 Dec;17(6):e1137-e1146. PMID: 31473122

Kang M, Yoo H, Kim K, Sung SH, Jeon HG, Park SH, Seo SI, Jeon SS, Lee HM, Choi HY, Jeong BC. Role of Adjuvant Chemotherapy in Advanced Stage Upper Urinary Tract Urothelial Carcinoma After Radical Nephroureterectomy: Competing Risk Analysis After Propensity Score-Matching. J Cancer. 2019 Nov 17;10(27):6896-6902. PMID: 31839824  

Kang M, Cho E, Jang J, Lee J, Jeon Y, Jeong BC, Seo SI, Jeon SS, Lee HM, Choi HY, Jeon HG. Genomic Analysis of Korean Patients With Advanced Prostate Cancer by Use of a Comprehensive Next-Generation Sequencing Panel and Low-Coverage, Whole-Genome Sequencing. Investig Clin Urol. 2019 Jul;60(4):227-234. PMID: 31294131

Kim S, Kim Y, Kong J, Kim E, Choi JH, Yuk HD, Lee H, Kim HR, Lee KH, Kang M, Roe JS, Moon KC, Kim S, Ku JH, Shin K. Epigenetic Regulation of Mammalian Hedgehog Signaling to the Stroma Determines the Molecular Subtype of Bladder Cancer. Elife. 2019 Apr 30;8:e43024. PMID: 31036156

Jeong CW, Kang M, Il Jung S, Kim TH, Park SW, Joung JY, Jeon SS, Hong JH, Lee JY, Chung BH, Ahn H, Kim CS, Kwon DD, Kwak C. Importance of Androgen-Deprivation Therapy During Enzalutamide Treatment in Men With Metastatic Castration-Resistant Prostate Cancer Following Chemotherapy: Results From Retrospective, Multicenter Data. Prostate Cancer Prostatic Dis. 2019 Mar;22(1):150-158. PMID: 30214035

Lee KH, Hong S, Kang M, Jeong CW, Ku JH, Kim HH, Kwak C. Histone Demethylase KDM7A Controls Androgen Receptor Activity and Tumor Growth in Prostate Cancer. Int J Cancer. 2018 Dec 1;143(11):2849-2861. PMID: 30183076

Kang M, Park JY, Jeong CW, Hwang EC, Song C, Hong SH, Kwak C, Chung J, Sung HH, Jeon HG, Jeong BC, Park SH, Jeon SS, Lee HM, Choi HY, Seo SI. Changeable Conditional Survival Rates and Associated Prognosticators in Patients With Metastatic Renal Cell Carcinoma Receiving First Line Targeted Therapy. J Urol. 2018 Nov;200(5):989-995. PMID: 29940249 

Kang M, Yu J, Sung HH, Jeon HG, Jeong BC, Park SH, Jeon SS, Lee HM, Choi HY, Seo SI. Prognostic Impact of the Pretreatment Aspartate Transaminase/Alanine Transaminase Ratio in Patients Treated With First-Line Systemic Tyrosine Kinase Inhibitor Therapy for Metastatic Renal Cell Carcinoma. Int J Urol. 2018 Jun;25(6):596-603. PMID: 29756394 

Kang M, Byun SS, Lee SE, Hong SK. Clinical Significance of Serum Adipokines According to Body Mass Index in Patients With Clinically Localized Prostate Cancer Undergoing Radical Prostatectomy. World J Mens Health. 2018 Jan;36(1):57-65. PMID: 29299904  

Kang M, Gong IH, Park HJ, Sung HH, Jeon HG, Jeong BC, Jeon SS, Lee HM, Choi HY, Il Seo S. Predictive Factors for Achieving Superior Pentafecta Outcomes Following Robot-Assisted Partial Nephrectomy in Patients With Localized Renal Cell Carcinoma. J Endourol. 2017 Dec;31(12):1231-1236. PMID: 26499308 

Kang M, Chang CT, Sung HH, Jeon HG, Jeong BC, Seo SI, Jeon SS, Choi HY, Lee HM. Prognostic Significance of Pre- To Postoperative Dynamics of the Prognostic Nutritional Index for Patients With Renal Cell Carcinoma Who Underwent Radical Nephrectomy. Ann Surg Oncol. 2017 Dec;24(13):4067-4075. PMID: 28975525  

Lee JH, Jeon YG, Lee KH, Lee HW, Park J, Jang H, Kang M, Lee HS, Cho HJ, Nam DH, Kwak C, Kim JB. RNF20 Suppresses Tumorigenesis by Inhibiting the SREBP1c-PTTG1 Axis in Kidney Cancer. Mol Cell Biol. 2017 Oct 27;37(22):e00265-17. PMID: 28827316

Kang M, Lee KH, Lee HS, Jeong CW, Ku JH, Kim HH, Kwak C. Concurrent Treatment With Simvastatin and NF-κB Inhibitor in Human Castration-Resistant Prostate Cancer Cells Exerts Synergistic Anti-Cancer Effects via Control of the NF-κB/LIN28/let-7 miRNA Signaling Pathway. PLoS One. 2017 Sep 14;12(9):e0184644. PMID: 28910332  

Kang M, Ku JH. Emerging Role of Liquid Biopsy of Cell-Free Tumor DNA for Bladder Cancer Surveillance. Transl Androl Urol. 2017 Jun;6(3):590-592. PMID: 28725603 

Kang M, Lee KH, Lee HS, Jeong CW, Kwak C, Kim HH, Ku JH. Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells. Int J Mol Sci. 2017 Feb 4;18(2):321. PMID: 28165387

Kang M, Ku JH. Liquid Biopsy? A Recent Breakthrough in Noninvasive Bladder Cancer Surveillance. Investig Clin Urol. 2016 Sep;57(5):307-8.  PMID: 27617310 

Kang M, Oh JJ, Lee S, Hong SK, Lee SE, Byun SS. Perineural Invasion and Lymphovascular Invasion Are Associated With Increased Risk of Biochemical Recurrence in Patients Undergoing Radical Prostatectomy. Ann Surg Oncol. 2016 Aug;23(8):2699-706. PMID: 26965702 

Kang M, Lee JK, Im YJ, Choi H, Park K. Predictive Factors of Chronic Kidney Disease in Patients With Vesicoureteral Reflux Treated Surgically and Followed After Puberty. J Urol. 2016 Apr;195(4 Pt 1):1100-6. PMID: 26555955 

Kang M, Lee KH, Lee HS, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C. PDLIM2 Suppression Efficiently Reduces Tumor Growth and Invasiveness of Human Castration-Resistant Prostate Cancer-Like Cells. Prostate. 2016 Feb 15;76(3):273-85. PMID: 26499308   

Kang M, Ho JN, Kook HR, Lee S, Oh JJ, Hong SK, Lee SE, Byun SS. Theracurmin® Efficiently Inhibits the Growth of Human Prostate and Bladder Cancer Cells via Induction of Apoptotic Cell Death and Cell Cycle Arrest. Oncol Rep. 2016 Mar;35(3):1463-72. PMID: 26718024  

Kang M, Jeong CW, Kwak C, Kim HH, Ku JH. The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients With Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy. Ann Surg Oncol. 2016 Jan;23(1):335-42. PMID: 26152275

Kang M, Kim HS, Jeong CW, Kwak C, Kim HH, Ku JH.  Prognostic Factors for Conditional Survival in Patients With Muscle-Invasive Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy. Sci Rep. 2015 Jul 27;5:12171. PMID: 26212449

Kang M, Lee HS, Lee YJ, Choi WS, Park YH, Jeong CW, Ku JH, Kim HH, Kwak C.  S100A3 Suppression Inhibits in Vitro and in Vivo Tumor Growth and Invasion of Human Castration-Resistant Prostate Cancer Cells. Urology. 2015 Jan;85(1):273.e9-15. PMID: 25440760

Kang M, Jeong CW, Ku JH, Kwak C, Kim HH. Inhibition of Autophagy Potentiates Atorvastatin-Induced Apoptotic Cell Death in Human Bladder Cancer Cells in Vitro. Int J Mol Sci. 2014 May 8;15(5):8106-21. PMID: 24815071  

Kang M, Kim HH, Han YM. Generation of Bladder Urothelium From Human Pluripotent Stem Cells Under Chemically Defined Serum- And Feeder-Free System. Int J Mol Sci. 2014 Apr 25;15(5):7139-57. PMID: 24776760

Kang M, Han YM. Differentiation of Human Pluripotent Stem Cells Into Nephron Progenitor Cells in a Serum and Feeder Free System. PLoS One. 2014 Apr 11;9(4):e94888. PMID: 24728509